The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Tonight will start off clear in many areas, but cloud will increase from the east overnight, bringing some light and patchy rain.
A rally planned by the families of the 304 people who died on the ferry disaster last year were sprayed with water cannon and pepper spray.
Four QPR hooligans caught on CCTV reeking havoc and attacking rival fans have been jailed.